Key Developments

In December 2022, CELLINK, and the Indian Institute of Science (IISc), announced that they had opened Center of Excellence (CoE) for 3D bioprinting for tissue engineering, regenerative medicine. The CoE will provide access to 3D bioprinting systems, enabling researchers to accelerate their work across critical applications with the ultimate goal of improving health outcomes.
In April 2022, Organogenesis Inc., a global leader in regenerative medicine, announced that the latest advanced wound care research on its PuraPly AM, Affinity, Apligraf, NuShield, Novachor, and Organogenesis Physician Solutions product lines would be showcased at the 2022 Symposium on Advanced Wound Care (SAWC) Spring Conference, held between April 6 and April 10, 2022, in, Arizona, U.S.
In May 2021, 3D Systems, Inc., a leading provider of 3D printing announced the acquisition of Allevi, Inc., is a technology company making 3 dimensional bioprinters and bioinks to expand regenerative medicine initiative by accelerating growth in medical and pharmaceutical research laboratories
In May 2021, 3D Systems, Inc., a leading provider of 3D printing, announced the acquisition of a Germany-based software firm, Additive Works GmbH, to expand simulation capabilities for rapid optimization of industrial-scale 3D printing processes